Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1992 Mar;15(3):185-90.
doi: 10.1007/BF03348702.

Octreotide therapy of growth hormone excess in the McCune-Albright syndrome

S I Sherman  1 , P W Ladenson
Affiliations
Case Reports

Octreotide therapy of growth hormone excess in the McCune-Albright syndrome

S I Sherman et al. J Endocrinol Invest. 1992 Mar.

Abstract

We report a patient with the McCune-Albright syndrome and growth hormone excess. Biochemical evaluation demonstrated characteristic changes typical of acromegaly, and an unusual pattern of delayed somatotropin response to hGHRH40, not previously described in this syndrome. Therapeutic trial of low-dose octreotide successfully reversed his growth hormone excess, whereas bromocriptine failed to reduce growth hormone levels. Previous reports of acromegaly and McCune-Albright syndrome are reviewed, and the unique features of this case discussed.

PubMed Disclaimer

References

    1. Acta Endocrinol Suppl (Copenh). 1986;279:207-17 - PubMed
    1. Horm Metab Res. 1989 Sep;21(9):527-8 - PubMed
    1. Pathol Annu. 1971;6:81-146 - PubMed
    1. Johns Hopkins Med J. 1981 Jul;149(1):10-4 - PubMed
    1. J Endocrinol Invest. 1982 Sep-Oct;5(5):323-6 - PubMed

Publication types

LinkOut - more resources